Supplementary flow cytometry technique reveals CD4+ and CD8+ T cell responses in treatment with an SHP2 inhibitor, implying enhanced therapy effectiveness.
Supplementary Figure S8. Representative flow cytometry gating strategy. A-C. Flow cytometry gating strategy for CD4+ and CD8+ T cells (A), IFNγ+ CD8+ T cells (B), and Macrophages (C).
No takes yet. Share an insight, caveat, or question.
Kang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: